Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-08

Clinical Trial Update: Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety, tolerability, and antidepressant effects of dimethyltryptamine (DMT) in adults with major depressive disorder; the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DMT (N,N-Dimethyltryptamine)

Snippet

Sponsor: Universidade Federal do Rio Grande do Norte | Conditions: Depressive Disorder, Depression, Unipolar | Phase 2 | Status: COMPLETED